Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ADMA Biologics Inc (ADMA) vs MasTec Inc (MTZ) Price & Performance

ADMA Biologics IncTrade
MasTec IncTrade

Price performance (Past 24H)

Key statistics

ADMA Biologics Inc vs MasTec Inc — how do they compare? ADMA Biologics Inc trades at $9.86 (market cap $2.22B), while MasTec Inc trades at $284.58 (market cap $21.90B). The key difference: MasTec Inc is far larger — about 9.9× ADMA Biologics Inc's market cap, and MasTec Inc is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.

ADMAMTZ
Market Cap
$2.22B$21.90B
Sector
HealthTechnology
52-Week High
$20.38$437.51
52-Week Low
$7.60$172.51
Enterprise Value
$2.29B$24.81B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About ADMA Biologics Inc

ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.

Read more on ADMA

About MasTec Inc

MasTec, Inc. is a leading infrastructure construction company operating mainly in North America. The company's services cover a diverse range of end-markets, including communications (building fiber and wireless infrastructure), oil & gas, electric power (transmission, distribution, and clean energy), and industrial projects. MTZ provides critical engineering, procurement, and construction (EPC) services that support the expansion and maintenance of essential infrastructure across the continent.

Read more on MTZ